Tu Raymond H, Grewall Pam, Leung Joseph W, Suryaprasad Arun G, Sheykhzadeh Paul I, Doan Caitlin, Garcia Juan Carlos, Zhang Nan, Prindiville Thomas, Mann Surinder, Trudeau Walter
Department of Transplantation, The Permanente Medical Group, Inc, Santa Teresa Medical Center, San Jose, California, USA.
Gastrointest Endosc. 2006 Jan;63(1):87-94. doi: 10.1016/j.gie.2005.08.015.
Intravenous benzodiazepines in combination with opiates are used to achieve moderate sedation for colonoscopy. Although effective, these agents have potential adverse effects, such as respiratory depression and hypotension. Diphenhydramine hydrochloride possesses central nervous system depressant effects that theoretically could provide a synergistic effect for sedating patients.
The objective was to assess the efficacy of adding diphenhydramine hydrochloride as an adjunct to improve sedation and to reduce the amount of standard sedatives used during colonoscopy.
We conducted a prospective, randomized, double-blind, placebo-controlled study.
The study was conducted in a university hospital with an active GI fellowship training program.
The study group comprised 270 patients undergoing screening/diagnostic/therapeutic colonoscopy were enrolled.
Patients were randomized to receive either 50 mg of diphenhydramine or placebo, given intravenously 3 minutes before starting conscious sedation with intravenous midazolam and meperidine.
The main outcome measure was anesthetic effect as assessed by the endoscopy team and by the patient; quantity of adjunctive sedatives to achieve adequate sedation.
Of 270 patients, data were analyzed for 258 patients, with 130 patients in the diphenhydramine group and 128 patients in the placebo group. There was a 10.1% reduction in meperidine usage and 13.7% reduction in midazolam usage in favor of the diphenhydramine group. The mean evaluation scores as judged by the faculty, the fellows, and the nurses were statistically significant in favor of the diphenhydramine group. In addition, patient scores for overall sedation and pain level favored the group that received diphenhydramine.
Intravenous diphenhydramine given before initiation of standard sedation offers a significant benefit to conscious sedation for patients undergoing colonoscopy.
静脉注射苯二氮䓬类药物与阿片类药物联合使用,用于结肠镜检查时实现中度镇静。尽管这些药物有效,但它们有潜在的不良反应,如呼吸抑制和低血压。盐酸苯海拉明具有中枢神经系统抑制作用,理论上可为患者镇静提供协同效应。
评估添加盐酸苯海拉明作为辅助药物改善镇静效果并减少结肠镜检查期间标准镇静药物用量的疗效。
我们进行了一项前瞻性、随机、双盲、安慰剂对照研究。
该研究在一家设有活跃胃肠病学 fellowship 培训项目的大学医院进行。
研究组纳入了 270 例接受筛查/诊断/治疗性结肠镜检查的患者。
患者被随机分为两组,分别在开始静脉注射咪达唑仑和哌替啶进行清醒镇静前 3 分钟静脉注射 50 毫克盐酸苯海拉明或安慰剂。
主要观察指标是由内镜检查团队和患者评估的麻醉效果;达到充分镇静所需辅助镇静药物的用量。
270 例患者中,对 258 例患者的数据进行了分析,其中苯海拉明组 130 例,安慰剂组 128 例。苯海拉明组哌替啶用量减少了 10.1%,咪达唑仑用量减少了 13.7%。教员、住院医师和护士的平均评估得分在统计学上显著有利于苯海拉明组。此外,患者对总体镇静和疼痛程度的评分也有利于接受苯海拉明的组。
在开始标准镇静前静脉注射苯海拉明对接受结肠镜检查的患者的清醒镇静有显著益处。